MedTrace Logo

Drusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants Supplementation

NCT02264938 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2014-10-15

No results posted yet for this study

Summary

Purpose: To determine drusen morphology (volume and area) changes in nonexudative age-related macular degeneration (AMD) after one year of oral supplementation with AREDS-like formulation.

Conditions

  • Macular Degeneration

Interventions

DIETARY_SUPPLEMENT

Antioxidant

Oral supplemmentation with antioxidants

Sponsors & Collaborators

  • Germans Trias i Pujol Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-07-31
Completion
2014-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02264938 on ClinicalTrials.gov